国家: 英国
语言: 英文
来源: MHRA (Medicines & Healthcare Products Regulatory Agency)
Lamotrigine
Waymade Healthcare Plc
N03AX09
Lamotrigine
25mg
Dispersible tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04080100
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE USER LAMICTAL ® 25MG DISPERSIBLE/CHEWABLE TABLETS (lamotrigine) Lamictal Dispersible/Chewable Tablets are available in the following strengths: 2mg, 5mg, 25mg & 100mg. This leaflet only applies to the 25mg Dispersible/Chewable Tablets which will be referred to as Lamictal Dispersible/Chewable Tablets throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Lamictal Dispersible/Chewable Tablets are and what they are used for 2. What you need to know before you take Lamictal Dispersible/Chewable Tablets 3. How to take Lamictal Dispersible/Chewable Tablets 4. Possible side effects 5. How to store Lamictal Dispersible/Chewable Tablets 6. Contents of the pack and other information 1. WHAT LAMICTAL DISPERSIBLE/CHEWABLE TABLETS ARE AND WHAT THEY ARE USED FOR Lamictal Dispersible/Chewable Tablets belong to a group of medicines called _anti-epileptics_. They are used to treat two conditions - EPILEPSY and BIPOLAR DISORDER. LAMICTAL DISPERSIBLE/CHEWABLE TABLETS TREAT EPILEPSY by blocking the signals in the brain that trigger epileptic seizures (fits) For adults and children aged 13 years and over, Lamictal Dispersible/Chewable Tablets can be used on their own or with other medicines, to treat epilepsy. Lamictal Dispersible/Chewable Tablets can also be used with other medicines to treat the seizures that occur with a condition called Lennox-Gastaut syndrome. For children aged between 2 and 12 years, Lamictal Dispersibl 阅读完整的文件
PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Not applicable 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Not applicable 3. PHARMACEUTICAL FORM Not applicable 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Not applicable 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Not applicable 4.3. CONTRAINDICATIONS Not applicable 4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE Not applicable 4.5. INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Not applicable 4.6. PREGNANCY AND LACTATION Not applicable 4.7. EFFECTS ON ABILITY TO DRIVE AND USE MACHINES Not applicable 4.8. UNDESIRABLE EFFECTS Not applicable 4.9. OVERDOSE Not applicable 5. PHARMACOLOGICAL PROPERTIES 5.1. PHARMACODYNAMIC PROPERTIES Not applicable 5.2. PHARMACOKINETIC PROPERTIES Not applicable 5.3. PRECLINICAL SAFETY DATA Not applicable 6. PHARMACEUTICAL PARTICULARS 6.1. LIST OF EXCIPIENTS Not applicable 6.2. INCOMPATIBILITIES Not applicable 6.3. SHELF LIFE Not applicable 6.4. SPECIAL PRECAUTIONS FOR STORAGE Not applicable 6.5. NATURE AND CONTENTS OF CONTAINER Not applicable 6.6. INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL) Not applicable No Data Held ADMINISTRATIVE DATA 7. MARKETING AUTHORISATION HOLDER Not applicable 8. MARKETING AUTHORISATION NUMBER Not applicable 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Not applicable 10. DATE OF REVISION OF THE TEXT Not applicable 阅读完整的文件